LOW
34
-5
INTC
50
-3
AMG
69
-6
EIX
34
-3
DAL
70
-4
FLR
55
-4
CNP
49
-3
DLTR
56
-2
DRI
43
-2
SPG
37
-4
GME
41
-3
IP
60
-5
AEP
59
-2
L
47
-5
COP
39
-3
APA
34
-4
ALLE
30
-5
VMC
60
-8
ADT
66
-5
HIG
48
-3
LOW
34
-5
INTC
50
-3
AMG
69
-6
EIX
34
-3
DAL
70
-4
FLR
55
-4
CNP
49
-3
DLTR
56
-2
DRI
43
-2
SPG
37
-4
GME
41
-3
IP
60
-5
AEP
59
-2
L
47
-5
COP
39
-3
APA
34
-4
ALLE
30
-5
VMC
60
-8
ADT
66
-5
HIG
48
-3
Financhill
Back

Kiniksa Pharmaceuticals International PLC 10K Form

Buy
59

KNSA
Kiniksa Pharmaceuticals International PLC

Last Price:
$28.06
Seasonality Move:
4.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KNSA News And Ratings

See the #1 stock for the next 7 days that we like better than KNSA

KNSA Financial Statistics

Sales & Book Value

Annual Sales: $423.2M
Cash Flow: $22.2M
Price / Cash Flow: 46.76
Annual Sales: $6.28
Price / Book: 4.48

Profitability

EPS (TTM): -0.25000
Net Income (TTM): $-17M
Gross Margin: $362.3M
Return on Equity: -3.85%
Return on Assets: -3.03%

Kiniksa Pharmaceuticals International PLC Earnings Forecast

Key Kiniksa Pharmaceuticals International PLC Financial Ratios

  • The Gross Profit Margin over the past 6 years for KNSA is 85.61%.
  • The Selling, General & Administrative Expenses for KNSA have been equal to 39.70% of Gross Profit Margin.
  • The Research & Development expenses have been 26.37% of Revenue.
  • The Net Earning history of KNSA is -10.21% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Kiniksa Pharmaceuticals International PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KNSA
CUSIP: G5269C
Website: kiniksa.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.66
Quick Ratio: 3.17

Price-to-Earnings

Trailing P/E Ratio: 98.63
Forward P/E Ratio: 18.64

KNSA Technical Analysis vs Fundamental Analysis

Buy
59
Kiniksa Pharmaceuticals International PLC (KNSA) is a Buy

Is Kiniksa Pharmaceuticals International PLC a Buy or a Sell?